[1]Xiao Y, Yuan T, Yao W, Liao K. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor- gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway. FEBS Journal, 2010, 277(3): 687-696.[2]Ambati S, Kim H K, Yang J Y, Lin J, Della-Fera M A, Baile C A. Effects of leptin on apoptosis and adipogenesis in 3T3-L1 adipocytes. Biochem Pharmacol, 2007, 73(3): 378-384.[3]Birk R Z, Rubinstein M. IFN-alpha induces apoptosis of adipose tissue cells. Biochemical and Biophysical Research Communications, 2006, 345(2): 669-674.[4]Bai L, Pang W J, Yang Y J, Yang G S. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Molecular and Cellular Biochemistry, 2008, 307(1-2): 129-140.[5]Liu J J, Hu T, Wu X Y, Wang C Z, Xu Y, Zhang Y, Xiao R Z, Lin D J, Huang R W, Liu Q. Peroxisome proliferator-activated receptor- gamma agonist rosiglitazone--induced apoptosis in leukemia k562 cells and its mechanisms of action. International Journal of Toxicology, 2009, 28(2): 123-131.[6]Kilter H, Werner M, Roggia C, Reil J C, Schafers H J, Kintscher U, Bohm M. The PPAR-gamma agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation. Diabetes, Obesity and Metabolism, 2009, 11(11): 1060-1067.[7]Rhee S D, Sung Y Y, Jung W H, Cheon H G. Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes. Molecular and Cellular Endocrinology, 2008, 294(1-2): 61-69.[8]Pal P, Kanaujiya J K, Lochab S, Tripathi S B, Sanyal S, Behre G, Trivedi A K. Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes. Molecular and Cellular Biochemistry, 2013, 376(1-2): 81-93.[9]Riederer M, Erwa W, Zimmermann R, Frank S, Zechner R. Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. Atherosclerosis, 2009, 204(2): 412-417.[10]Crowley C L, Payne C M, Bernstein H, Bernstein C, Roe D. The NAD+ precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate. Cell Death and Differentiation, 2000, 7(3): 314-326.[11]Hoane M R, Kaplan S A, Ellis A L. The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury. Brain Research, 2006, 1125(1): 185-193.[12]张朝,杨扬,庞卫军,孙超,杨公社. 白藜芦醇对猪前体脂肪细胞凋亡的作用及机理. 生物工程学报,2010, 26(8): 1042-1049.Zhang Z, Yang Y, Pang W, Sun C, Yang G. Effect and underlying mechanism of resveratol on porcine primary preadipocyte apoptosis. Chinese Journal of Biotechnology, 2010, 26(8): 1042-1049. (in Chinese) [13]Pang W J, Yu T Y, Bai L, Yang Y J, Yang G S. Tissue expression of porcine FoxO1 and its negative regulation during primary preadipocyte differentiation. Molecular Biology Reports, 2009, 36(1): 165-176.[14]鞠大鹏,何晶晶,郑雪莉,赵丽丽,杨公社. 雌激素受体关联受体α调节脂肪细胞甘油三酯分解. 生物工程学报,2011, 27(1): 18-25. Ju D, He J, Zheng X, Zhao L, Yang G. Role of estrogen-related receptor alpha in adipocyes lipolysis. Chinese Journal of Biotechnology, 2011, 27(1): 18-25. (in Chinese) [15]Gomes D A, Rodrigues M A, Leite M F, Gomez M V, Varnai P, Balla T, Bennett A M, Nathanson M H. c-Met must translocate to the nucleus to initiate calcium signals. Journal of Biological Chemistry, 2008, 283(7): 4344-4351.[16]Sorisky A, Magun R, Gagnon A M. Adipose cell apoptosis: death in the energy depot. International Journal of Obesity and Related Metabolic Disorders, 2000, 24 (Suppl. 4):3-7.[17]Henry S L, Bensley J G, Wood-Bradley R J, Cullen-McEwen L A, Bertram J F, Armitage J A. White adipocytes: more than just fat depots. International Journal of Biochemistry & Cell Biology, 2012, 44(3): 435-440.[18]Alkhouri N, Gornicka A, Berk M P, Thapaliya S, Dixon L J, Kashyap S, Schauer P R, Feldstein A E. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. Journal of Biological Chemistry, 2010, 285(5): 3428-3438.[19]Prins J B, O'Rahilly S. Regulation of adipose cell number in man. Clinical Science (London), 1997, 92(1): 3-11.[20]Liu J J, Xu Y, Zhang Y, Xiao R Z, Lin D J. Peroxisome proliferator-activated receptor γ (PPARγ) agonist rosiglitazone (RGZ) inhibits HL-60 cell growth by induction of apoptosis. Labmedicine, 2009, 40(5): 297-302.[21]Wu J, Lei M X, Xie X Y, Liu L, She Y M, Mo J, Wang S. Rosiglitazone inhibits high glucose-induced apoptosis in human umbilical vein endothelial cells through the PI3K/Akt/eNOS pathway. Canadian Journal of Physiology and Pharmacology, 2009, 87(7): 549-555.[22]Weissgarten J, Berman S, Efrati S, Rapoport M, Averbukh Z, Feldman L. Apoptosis and proliferation of cultured mesangial cells isolated from kidneys of rosiglitazone-treated pregnant diabetic rats. Nephrology Dialysis Transplantation, 2006, 21(5): 1198-1204.[23]Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado DOR, Leid M, McBurney M W, Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature, 2004, 429(6993): 771-776.[24]Schwer B, Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metabolism, 2008, 7(2):104-112.[25]Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S, Isono M, Isshiki K, Uzu T, Kashiwagi A, Koya D. Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation. Free Radical Biology and Medicine, 2006, 40(12): 2175-2182.[26]Han M K, Song E K, Guo Y, Ou X, Mantel C, Broxmeyer H E. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell, 2008, 2(3): 241-251.[27]Takayama K, Ishida K, Matsushita T, Fujita N, Hayashi S, Sasaki K, Tei K, Kubo S, Matsumoto T, Fujioka H, Kurosaka M, Kuroda R. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis & Rheumatism, 2009, 60(9): 2731-2740.[28]Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Washida N, Tokuyama H, Hayashi K, Itoh H. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochemical and Biophysical Research Communications, 2008, 372(1): 51-56.[29]Le Goff A, Ji Z, Leclercq B, Bourette R P, Mougel A, Guerardel C, de Launoit Y, Vicogne J, Goormachtigh G, Fafeur V. Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling. Journal of Biological Chemistry, 2012, 287(42): 35382-35396.[30]Shimbo K, Hsu G W, Nguyen H, Mahrus S, Trinidad J C, Burlingame A L, Wells J A. Quantitative profiling of caspase-cleaved substrates reveals different drug-induced and cell-type patterns in apoptosis. Proceedings of the National Academy of Sciences of USA, 2012, 109(31): 12432-12437.[31]Pang W J, Xiong Y, Zhang Z, Wei N, Chen N, Yang G S. Lentivirus-mediated Sirt1 shRNA and resveratrol independently induce porcine preadipocyte apoptosis by canonical apoptotic pathway. Molecular Biology Reports, 2013, 40(1): 129-139.[32]Pang W J, Xiong Y, Wang Y, Tong Q, Yang G S. Sirt1 attenuates camptothecin-induced apoptosis through caspase-3 pathway in porcine preadipocytes. Experimental Cell Research, 2013, 319(5):670-683. |